PF-04995274 Uses, Dosage, Side Effects and more
Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274).
| Trade Name | PF-04995274 |
| Generic | PF-04995274 |
| Type | |
| Formula | C23H32N2O6 |
| Weight | Average: 432.517 Monoisotopic: 432.226036758 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
